Enhancing medication adherence in patients with bipolar disorder (Human Psychopharmacology Clin Exp (2010) 25, (1-16) DOI: 10.1002/hup.1081);Enhancing medication adherence in patients with bipolar disorder

Human Psychopharmacology

Volumn 25, Issue 1, 2010, Pages 1-16

  Berk, Lesley ^a,b,c   Hallam, Karen T ^a,c,f   Colom, Francesc ^e   Vieta, Eduard ^e   Hasty, Melissa ^c   Macneil, Craig ^c   Berk, Michael ^a,b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BARWON HEALTH   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e UNIVERSITY OF BARCELONA   (Spain)

^f VICTORIA UNIVERSITY   (Australia)

Author keywords

Adherence; Bipolar disorder; Psychosocial intervention; Treatment

Indexed keywords

LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

BIPOLAR DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; DRUG BLOOD LEVEL; FUTUROLOGY; HEALTH BEHAVIOR; HUMAN; KNOWLEDGE; MEDICAL LITERATURE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

EID: 76149089101     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1107     Document Type: Erratum

References (101)

1. Adams J, Scott J. 2000. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 101: 119-124.
2. Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, Kessler RC. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64: 543-552.
3. Angst F, Stassen HH, Clayton PJ, Angst J. 2002. Mortality of patients with mood disorders: follow-up over34-38 years. J Affect Disord 68: 167-181.
4. Angst J, Angst F, Gerber-Werder R, Gamma A. 2005. Suicide in 406 mooddisorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 9: 279-300.
5. Ayuso-Mateos JL. 2000. Global burden of bipolar disorder in the year2000.-WHO. Global Burden of Disease.
6. Baldessarini RJ, Tondo L, Viguera AC. 1999. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1: 17-24.
7. Baldessarini RJ, Tondo L, David P, Pompili M, Goodwin FK, Hennen J. 2006. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 8: 625-639.
8. Baldessarini RJ, Perry R, Pike J. 2008. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol 23: 95-105.
9. Ball JR, Mitchell PB, Corry JC, Skillecorn A, Smith M, Malhi GS. 2006. A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. J Clin Psychiatry 67: 277-286.
10. Bearden CE, Thompson P, Dalwani M, et al. 2007. Greater cortical grey matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62: 7-16.
11. Berk M, Berk L, Castle D. 2004. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord 6: 504-518.
12. Berk L, Macneil C, Castle D, Berk M. 2008. The importance of the treatment alliance in bipolar disorder. In Psychotherapies for the Psychoses, Gleeson JFM, Killackey E, Krstev H (eds). Routledge: Britain.
13. Berk M, Conus P, Lucas N, et al. 2007. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9: 671-678.
14. Bowskill R, Clatworthy J, Parham R, Rank T, Horne R. 2007. Patients' perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord 100: 253-257.
15. Bultman DC, Svarstad BL. 2002. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc (Wash) 42: 36-43.
16. Burdick KE, Braga RJ, Goldberg JF, Malhotra AK. 2007. Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy. CNS Drugs 21: 971-981.
17. Byerly M, Fisher R, Whatley K, et al. 2005. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 133: 129-133.
18. Cavanagh J, Smyth R, Goodwin GM. 2004. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand 109: 91-95.
19. Chang K, Karchemsky A, Barnea-Goraly N, Garrett A, Simeonova D, Reiss A. 2005. Reduced amygdalar grey matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44: 565-573.
20. Clarkin JF, Carpenter D, Hull J, Wilner P, Glick I. 1998. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatr. Serv 49: 531-533.
21. Clatworthy J, Bowskill R, Rank T, Parham R, Horne R. 2007. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients beliefs about the condition and its treatment. Bipolar Disorders 9: 656-664.
22. Cochran SD. 1984. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 52: 873-878.
23. Cochran SD, Gitlin MJ. 1988. Attitudinal correlates of lithium compliance in bipolar affective disorders. J Nerv Ment Dis 176: 457-464.
24. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. 2000. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 61: 549-555.
25. Colom F, Vieta E. 2002. Treatment adherence in bipolar patients. Clin Approach Bipolar Disorder 1: 49-56.
26. Colom F, Vieta E, Martinez-Aran A, et al. 2003. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60: 402-407.
27. Colom F, Vieta E, Sanchez-Moreno J, et al. 2005a. Stabilizing the stabilizer, group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord 7: 32-36.
28. Colom F, Vieta E, Tacchi MJ, Sanchez-Moreno J, Scott J. 2005b. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 7(Suppl 5): 24-31.
29. Colom F, Vieta E, SÃ nchez-Moreno J, et al. 2009. Group psychoeducation for stabilized bipolar disorders: 5-year outcome of a randomized clinical trial. Br J Psychiatry 194: 260-265.
30. Connelly CE, Davenport YB, Nurnberger JI Jr. 1982. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 39: 585-588.
31. Copeland l, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. 2008. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis 196: 16-21.
32. Darling CA, Olmstead SB, Lund V, Walker J. 2008. Bipolar Disorder: Medication Adherence and Life Contentment. Arch Psychiatr Nurs 22: 113-126.
33. Demyttenaere K, Haddad P. 2000. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr Scand 403 (Suppl): 50-56.
34. Depp CA, Lebowitz BD, Patterson TL, Lacro JP, Jeste DV. 2007. Medication adherence skills training for middle aged and elderly adults with bipolar disorder, development and pilot study. Bipolar Disorder 9: 636-645.
35. Dharmendra MS, Eagles JM. 2003. Factors associated with patients' knowledge of and attitudes towards treatment with lithium. J Affect Disord 75: 29-33.
36. Dogan S, Sabanciogullari S. 2003. The effects of patient education in lithium therapy on quality of life and compliance. Arch Psychiatr Nurs 17: 270-275.
37. Dolder CR, Lacro JP, Dunn LB, Jeste DV. 2002. Antipsychotic medication adherence, is there a difference between typical and atypical agents? Am J Psychiatry 159: 103-108.
38. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. 1993. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 50: 448-455.
39. Franchini L, Zanardi R, Smeraldi E, Gasperini M. 1999. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 249: 227-230.
40. Frank E, Kupfer DJ, Thase ME, et al. 2005. Two year outcomes for interpersonal and social rhythm therapy in individuals with Bipolar I Disorder. Arch Gen Psychiatry 62: 996-1004.
41. Gaudiano BA, Weinstock LM, Miller IW. 2008. Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif 32: 267.
42. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. 2004. Longterm lithium therapy for bipolar disorder, systematic review and metaanalysis of randomized controlled trials. Am J Psychiatry 161: 217-222.
43. Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH. 2006. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. J Clin Psychiatry 67: 222-232.
44. Gitlin MJ, Cochran SD, Jamison KR. 1989. Maintenance lithium treatment, side effects and compliance. J Clin Psychiatry 50: 127-131.
45. Gitlin MJ, Swendsen J, Heller TL, Hammen C. 1995. Relapse and impairment in bipolar disorder. Am J Psychiatry 152: 1635-1640.
46. Gonzalez-Pinto A, Mosquera F, Alonso M, et al. 2006. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord 8: 618-624.
47. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. 2003. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290: 1467-1473.
48. Havens LL, Ghaemi SN. 2005. Existential despair and bipolar disorder, the therapeutic alliance as a mood stabilizer. Am J Psychother 59: 137-147.
49. Johnson RE, McFarland BH. 1996. Lithium use and discontinuation in a health maintenance organisation. Am J Psychiatry 153: 993-1000.
50. Johnson SL, Fulford D. 2008. Development of the treatment attitudes questionnaire in bipolar disorder. J Clin Psychol 64: 466-481.
51. Jones SH, Sellwood W, McGovern J. 2005. Psychological therapies for bipolar disorder, the role of model-driven approaches to therapy integration. Bipolar Disord 7: 22-32.
52. Keck PE Jr, McElroy SL, Strakowski SM, et al. 1996. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 57: 292-297.
53. Keck PE Jr, McElroy SL, Strakowski SM, et al. 1998. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 155: 646-652.
54. Kessing LV, Sondergard L, Kvist K, Andersen PK. 2007. Adherence to lithium in naturalistic settings,results froma nationwide pharmacoepidemiological study. Bipolar Disord 9: 730-736.
55. Kleindienst N, Greil W. 2004. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? J Clin Psychiatry 65: 966-974.
56. Lam DH, Hayward P, Watkins ER, Wright K, Sham P. 2005. Relapse prevention in patients with bipolar disorder, Cognitive therapy outcome after two years. Am J Psychiatry 162: 324-329.
57. Lee S, Wing YK, Wong KC. 1992. Knowledge and compliance towards lithium therapy among Chinese psychiatric patients in Hong Kong. Aust N Z J Psychiatry 26: 444-449.
58. Lingam R, Scott J. 2002. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105: 164-172.
59. Manwani SG, Szilagyi KA, Zabottsky B, Hennen J, Griffin ML, Weiss RD. 2007. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry 68: 1172-1176.
60. McGorry PD, McConville SB. 1999. Insight in psychosis, an elusive target. Compr Psychiatry 40: 131-142.
61. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, Snyder KS, Doane JA. 1986. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacol Bull 22: 628-632.
62. Miklowitz DJ. 1992. Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. J Nerv Ment Dis 180: 703-711.
63. Miklowitz DJ, 2006. A review of evidence-based psychosocial interventions for bipolar disorder. J Clin Psychiatry 67(Suppl 11): 28-33.
64. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. 2003. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 60: 904-912.
65. Miklowitz DJ, Taylor DO. 2006. Family-focused treatment of the suicidal bipolar patient. Bipolar Disord 8: 640-651.
66. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. 2000. Lithiuminduced increase in human brain grey matter. Lancet 356: 1241-1242.
67. Morselli PL, Elgie R, Cesana BM. 2003. GAMIAN-Europe/BEAM survey I- global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord 5: 265-278.
68. Morselli PL, Elgie R, Cesana BM. 2004. GAMIAN-Europe/BEAM survey II- cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord 6: 487-497.
69. Murray CJ, Lopez AD. 1996. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274: 740-743. Noble L. 1998. Doctor-patient communication and adherence to treatment. In Adherence to treatment in medical conditions, Myers L, Mdence K (eds). Wiley: London; 51-82.
70. Peet M, Harvey NS. 1991. Lithium maintenance, 1. A standard education programme for patients. Br J Psychiatry 158: 197-200.
71. Perlick DA, Rosenheck RA, Clarkin JF, et al. 2004. Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatr Serv 9: 1029-1035.
72. Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. 1999. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 318: 149-153.
73. Pomykacz B, Mao M, Weiss RD, Teter CJ. 2007. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry 15: 259-263.
74. Pope M, Scott J. 2003. Do clinicians understand why individuals stop taking lithium? J Affect Disord 74: 287-291.
75. Rea MM, Tompson M, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J. 2003. Family focused treatment vs.individual treatment for bipolar disorder, results of a randomized clinical trial. J Consult Clin Psychol 71: 482-492.
76. Reed JF, Ozdemir S, Manjunath R, Hauber AAB, Burch SP, Thompson TR. 2007. Factors that affect adherence to bipolar treatments, a stated preference approach. Med Care 45: 545-552.
77. Rosa AR, Marco M, Fachel JM, Kapczinski F, Stein AT, Barros HM. 2007. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 31: 217-224.
78. Sachs GS, Rush AJ. 2003. Response, remission, and recovery in bipolar disorders, what are the realistic treatment goals? J Clin Psychiatry 64(Suppl 6): 18-22.
79. Sajatovic M, Blow FC, Kales HC, Valenstein M, Ganoczy D, Ignacio RV. 2007a. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int J Geriatr Psychiatry 22: 992-998.
80. Sajatovic M, Chen PJ, Dines P, Shirley ER. 2007b. Psychoeducational approaches to medication adherence in patients with bipolar disorder. Dis Manag Health Out 15: 181-192.
81. Sajatovic M, Davies M, Bauer MS, et al. 2005. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry 46: 272-277.
82. Sajatovic M, Davies M, Hrouda DR. 2004. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 55: 264-269.
83. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. 2006. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 8: 232-241.
84. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. 2007c. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 58: 855-863.
85. Sassi R, Brambilla P, Hatch J, et al. 2004. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 56: 467-475.
86. Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatr 2000. 12: 128-130.
87. Scott J. 2006. Psychotherapy for bipolar disorders - efficacy and effectiveness. J Psychopharmacol 20: 46-50.
88. Scott J, Paykel E, Morriss R, et al. 2006. Cognitive-behavioural therapy for severe and recurrent bipolar disorders - Randomised controlled trial. Br J Psychiatry 188: 313-320.
89. Scott J, Pope M. 2002a. Non-adherence with mood stabilisers, prevalence and predictors. J Clin Psychiatry 65: 384-390.
90. Scott J, Pope M. 2002b. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 159: 1927-1929.
91. Scott J, Tacchi MJ. 2002. A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. Bipolar Disord 4: 386-392.
92. Shaltiel G, Chen G, Manji HK. 2007. Neurotrophic signalling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 7: 22-26.
93. Sher I, McGinn L, Sirey JA, Meyers B. 2005. Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. Psychiatr Serv 56: 564-569.
94. Simon GE, Ludman EJ, Bauer MS, Unutzer J, Operskalski B. 2006. Longterm effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 63: 500-508.
95. Strauss JL, Johnson SL. 2006. Role of treatment alliance in the clinical management of bipolar disorder, stronger alliances prospectively predict fewer manic symptoms. Psychiatry Res 145: 215-223.
96. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. 1991. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 48: 1082-1088.
97. Svarstad BL, Shireman TI, Sweeney JK. 2001. Using drug claims data to assess the relationship of medication adherence with hospitalisation and costs. Psychiatr Serv 52: 805-811.
98. van Gent EM, Zwart FM. 1991. Psychoeducation of partners of bipolarmanic patients. J Affect Disord 21: 15-18.
99. Vieta E. 2005. Improving treatment adherence in bipolar disorder through psychoeducation. J Clin Psychiatry 66(Suppl 1): 24-29.
100. Wright E. 1993. Non-compliance or how many aunts has Matilda? Lancet 342: 909-913.
101. Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. 2008. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord 107: 53-62.